

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 7.84523826 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.84523826 |
| 3 | cellular response to interleukin-15 (GO:0071350) | 7.60302001 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.54503548 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.18330251 |
| 6 | response to interleukin-15 (GO:0070672) | 7.06170450 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.71984262 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.58004724 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.32009418 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.20133871 |
| 11 | activated T cell proliferation (GO:0050798) | 6.16971761 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.08845129 |
| 13 | leukocyte aggregation (GO:0070486) | 5.66689256 |
| 14 | negative T cell selection (GO:0043383) | 4.88629985 |
| 15 | negative thymic T cell selection (GO:0045060) | 4.84561302 |
| 16 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.81993249 |
| 17 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.81993249 |
| 18 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.55773843 |
| 19 | interferon-gamma production (GO:0032609) | 4.43000520 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 4.42570483 |
| 21 | positive thymic T cell selection (GO:0045059) | 4.41407821 |
| 22 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.36361001 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 4.28936804 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 4.28420323 |
| 25 | B cell receptor signaling pathway (GO:0050853) | 4.27033331 |
| 26 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.25254477 |
| 27 | positive T cell selection (GO:0043368) | 4.24752289 |
| 28 | negative regulation of T cell mediated immunity (GO:0002710) | 4.23987979 |
| 29 | regulation of B cell differentiation (GO:0045577) | 4.14384989 |
| 30 | cellular defense response (GO:0006968) | 4.12056673 |
| 31 | detection of bacterium (GO:0016045) | 4.11658428 |
| 32 | regulation of T cell tolerance induction (GO:0002664) | 4.05518203 |
| 33 | detection of other organism (GO:0098543) | 4.01614990 |
| 34 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.00098398 |
| 35 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.97940680 |
| 36 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.97707545 |
| 37 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.97470861 |
| 38 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.97167865 |
| 39 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.92996293 |
| 40 | type I interferon signaling pathway (GO:0060337) | 3.89273089 |
| 41 | cellular response to type I interferon (GO:0071357) | 3.89273089 |
| 42 | response to interferon-beta (GO:0035456) | 3.89060272 |
| 43 | response to type I interferon (GO:0034340) | 3.86843283 |
| 44 | negative regulation of interleukin-12 production (GO:0032695) | 3.83441853 |
| 45 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.77601757 |
| 46 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.77601757 |
| 47 | modulation by symbiont of host immune response (GO:0052553) | 3.77601757 |
| 48 | positive regulation by symbiont of host defense response (GO:0052509) | 3.77601757 |
| 49 | modulation by symbiont of host defense response (GO:0052031) | 3.77601757 |
| 50 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.77601757 |
| 51 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.72691176 |
| 52 | thymic T cell selection (GO:0045061) | 3.70336370 |
| 53 | T cell selection (GO:0045058) | 3.68470324 |
| 54 | cytidine deamination (GO:0009972) | 3.67453362 |
| 55 | cytidine metabolic process (GO:0046087) | 3.67453362 |
| 56 | cytidine catabolic process (GO:0006216) | 3.67453362 |
| 57 | T cell migration (GO:0072678) | 3.66275011 |
| 58 | regulation of cell killing (GO:0031341) | 3.64736851 |
| 59 | positive regulation of cell killing (GO:0031343) | 3.62641206 |
| 60 | positive regulation of B cell differentiation (GO:0045579) | 3.61776913 |
| 61 | cellular extravasation (GO:0045123) | 3.61517914 |
| 62 | neutrophil activation (GO:0042119) | 3.61262854 |
| 63 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.61059190 |
| 64 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.54060667 |
| 65 | regulation of tolerance induction (GO:0002643) | 3.51151055 |
| 66 | positive regulation of granulocyte differentiation (GO:0030854) | 3.47349442 |
| 67 | cellular response to interferon-beta (GO:0035458) | 3.46135046 |
| 68 | microglial cell activation (GO:0001774) | 3.45586284 |
| 69 | granulocyte activation (GO:0036230) | 3.40685004 |
| 70 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.38975728 |
| 71 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.38400057 |
| 72 | myeloid cell activation involved in immune response (GO:0002275) | 3.36516160 |
| 73 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.35937836 |
| 74 | hepatocyte apoptotic process (GO:0097284) | 3.27559406 |
| 75 | mast cell activation (GO:0045576) | 3.24942305 |
| 76 | positive regulation of tolerance induction (GO:0002645) | 3.23594292 |
| 77 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.17558076 |
| 78 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.16718168 |
| 79 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.16547326 |
| 80 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.14585808 |
| 81 | positive regulation of defense response to virus by host (GO:0002230) | 3.11465248 |
| 82 | T cell receptor signaling pathway (GO:0050852) | 3.10750436 |
| 83 | respiratory burst (GO:0045730) | 3.07908802 |
| 84 | leukocyte degranulation (GO:0043299) | 3.07101615 |
| 85 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.05649427 |
| 86 | positive regulation of isotype switching (GO:0045830) | 3.03989186 |
| 87 | negative regulation of innate immune response (GO:0045824) | 3.03742724 |
| 88 | positive regulation of mast cell activation (GO:0033005) | 3.01336823 |
| 89 | detection of external biotic stimulus (GO:0098581) | 3.00314108 |
| 90 | regulation of regulatory T cell differentiation (GO:0045589) | 2.98899793 |
| 91 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.94630520 |
| 92 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.93426922 |
| 93 | immunoglobulin mediated immune response (GO:0016064) | 2.89561844 |
| 94 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.87430897 |
| 95 | natural killer cell differentiation (GO:0001779) | 2.87110457 |
| 96 | regulation of T cell mediated immunity (GO:0002709) | 2.86341420 |
| 97 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.85640837 |
| 98 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.84942307 |
| 99 | response to host immune response (GO:0052572) | 2.82512008 |
| 100 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.82512008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 5.86398623 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.76607077 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.35394052 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.24821945 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.01968546 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.02626545 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.82850094 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.61999096 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.39644549 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.26971348 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.24887724 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 3.05506782 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.71051174 |
| 14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.63682510 |
| 15 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.63542519 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.58288616 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.58042339 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52478913 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.42520872 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.39901294 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31835434 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.27253944 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25527765 |
| 24 | UTX_26944678_Chip-Seq_JUKART_Human | 2.17797763 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.12788225 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.07993061 |
| 27 | SPI1_23127762_ChIP-Seq_K562_Human | 2.06401538 |
| 28 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.03558264 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.01969660 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93067742 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91613210 |
| 32 | MAF_26560356_Chip-Seq_TH2_Human | 1.84139989 |
| 33 | MYC_22102868_ChIP-Seq_BL_Human | 1.82643051 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.80387170 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76312426 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72876467 |
| 37 | GATA3_26560356_Chip-Seq_TH2_Human | 1.68756008 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.68433224 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.65752889 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58160954 |
| 41 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.56328430 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.52543373 |
| 43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.49762800 |
| 44 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.47459044 |
| 45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42591170 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42035993 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.40824182 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39879384 |
| 49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.39810028 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37275576 |
| 51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30937074 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22603359 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21836081 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21483780 |
| 55 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18322092 |
| 56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17712666 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15960065 |
| 58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15935246 |
| 59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.11088071 |
| 60 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10741196 |
| 61 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10379278 |
| 62 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10200232 |
| 63 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09021046 |
| 64 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.08403193 |
| 65 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08307951 |
| 66 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04958205 |
| 67 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02860360 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01332907 |
| 69 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01019331 |
| 70 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97584245 |
| 71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97511273 |
| 72 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97442986 |
| 73 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96084172 |
| 74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95690171 |
| 75 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.94086627 |
| 76 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.93295193 |
| 77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91865494 |
| 78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89330144 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89018580 |
| 80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87811048 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87760750 |
| 82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87446866 |
| 83 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87297321 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83695888 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83132433 |
| 86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.82030222 |
| 87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80933015 |
| 88 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80142099 |
| 89 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.80013854 |
| 90 | GATA3_26560356_Chip-Seq_TH1_Human | 0.78904957 |
| 91 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76442918 |
| 92 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73929389 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72625249 |
| 94 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.72273555 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.71516863 |
| 96 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71021694 |
| 97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.70578588 |
| 98 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69065868 |
| 99 | GATA1_22025678_ChIP-Seq_K562_Human | 0.68215613 |
| 100 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.67678176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.82562484 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.35211086 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.11635072 |
| 4 | MP0006082_CNS_inflammation | 3.94416840 |
| 5 | MP0003436_decreased_susceptibility_to | 3.51034936 |
| 6 | MP0003724_increased_susceptibility_to | 3.29048158 |
| 7 | MP0001800_abnormal_humoral_immune | 3.25922801 |
| 8 | MP0005387_immune_system_phenotype | 3.05631352 |
| 9 | MP0001790_abnormal_immune_system | 3.05631352 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.95794623 |
| 11 | MP0005025_abnormal_response_to | 2.87497629 |
| 12 | MP0002723_abnormal_immune_serum | 2.83415008 |
| 13 | MP0000685_abnormal_immune_system | 2.77777418 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.75733100 |
| 15 | MP0001819_abnormal_immune_cell | 2.72305419 |
| 16 | MP0002419_abnormal_innate_immunity | 2.71743793 |
| 17 | MP0009785_altered_susceptibility_to | 2.65935907 |
| 18 | MP0003183_abnormal_peptide_metabolism | 2.58432543 |
| 19 | MP0009333_abnormal_splenocyte_physiolog | 2.58349238 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.56535930 |
| 21 | MP0002405_respiratory_system_inflammati | 2.42458286 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.34416233 |
| 23 | MP0000703_abnormal_thymus_morphology | 2.28449503 |
| 24 | MP0002398_abnormal_bone_marrow | 2.20554073 |
| 25 | MP0000716_abnormal_immune_system | 2.12848231 |
| 26 | MP0003303_peritoneal_inflammation | 1.95539341 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.90720193 |
| 28 | MP0002722_abnormal_immune_system | 1.89702485 |
| 29 | MP0000689_abnormal_spleen_morphology | 1.89446041 |
| 30 | MP0003866_abnormal_defecation | 1.81479698 |
| 31 | MP0001851_eye_inflammation | 1.79108971 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.77486011 |
| 33 | MP0002132_abnormal_respiratory_system | 1.71415525 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.67943374 |
| 35 | MP0003690_abnormal_glial_cell | 1.66556699 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.65495058 |
| 37 | MP0004381_abnormal_hair_follicle | 1.65130747 |
| 38 | MP0002429_abnormal_blood_cell | 1.61550468 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.51430914 |
| 40 | MP0001873_stomach_inflammation | 1.50709768 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.50202431 |
| 42 | MP0001853_heart_inflammation | 1.49934561 |
| 43 | MP0000858_altered_metastatic_potential | 1.38544452 |
| 44 | MP0008057_abnormal_DNA_replication | 1.38418270 |
| 45 | MP0008469_abnormal_protein_level | 1.34470679 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.33763141 |
| 47 | MP0004947_skin_inflammation | 1.32283575 |
| 48 | MP0004883_abnormal_blood_vessel | 1.26109796 |
| 49 | MP0005310_abnormal_salivary_gland | 1.25510307 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.24968870 |
| 51 | MP0003045_fibrosis | 1.22862958 |
| 52 | MP0004142_abnormal_muscle_tone | 1.19437717 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 1.17990350 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.16699682 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.07169530 |
| 56 | MP0000569_abnormal_digit_pigmentation | 1.05748458 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 0.98779541 |
| 58 | MP0005377_hearing/vestibular/ear_phenot | 0.97934780 |
| 59 | MP0003878_abnormal_ear_physiology | 0.97934780 |
| 60 | MP0009764_decreased_sensitivity_to | 0.92603797 |
| 61 | MP0009763_increased_sensitivity_to | 0.92489421 |
| 62 | MP0002006_tumorigenesis | 0.88468992 |
| 63 | MP0001986_abnormal_taste_sensitivity | 0.87532922 |
| 64 | MP0008260_abnormal_autophagy | 0.86108719 |
| 65 | MP0005166_decreased_susceptibility_to | 0.83625121 |
| 66 | MP0004130_abnormal_muscle_cell | 0.82539967 |
| 67 | MP0002332_abnormal_exercise_endurance | 0.82382575 |
| 68 | MP0003448_altered_tumor_morphology | 0.81169741 |
| 69 | MP0005164_abnormal_response_to | 0.81060196 |
| 70 | MP0005451_abnormal_body_composition | 0.80944000 |
| 71 | MP0002933_joint_inflammation | 0.80231386 |
| 72 | MP0002163_abnormal_gland_morphology | 0.71856777 |
| 73 | MP0000015_abnormal_ear_pigmentation | 0.69619042 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 0.66952619 |
| 75 | MP0003828_pulmonary_edema | 0.65854895 |
| 76 | MP0004510_myositis | 0.64857416 |
| 77 | MP0003075_altered_response_to | 0.64539123 |
| 78 | MP0000920_abnormal_myelination | 0.64379375 |
| 79 | MP0009278_abnormal_bone_marrow | 0.63766482 |
| 80 | MP0002019_abnormal_tumor_incidence | 0.62205225 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 0.60643460 |
| 82 | MP0008873_increased_physiological_sensi | 0.60151107 |
| 83 | MP0001663_abnormal_digestive_system | 0.59601090 |
| 84 | MP0002693_abnormal_pancreas_physiology | 0.59464570 |
| 85 | MP0005376_homeostasis/metabolism_phenot | 0.57425456 |
| 86 | MP0005645_abnormal_hypothalamus_physiol | 0.57113004 |
| 87 | MP0005390_skeleton_phenotype | 0.56875122 |
| 88 | MP0000249_abnormal_blood_vessel | 0.56096117 |
| 89 | MP0003795_abnormal_bone_structure | 0.52796792 |
| 90 | MP0000604_amyloidosis | 0.52582910 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.49570909 |
| 92 | MP0005266_abnormal_metabolism | 0.49379847 |
| 93 | MP0002009_preneoplasia | 0.49193553 |
| 94 | MP0000490_abnormal_crypts_of | 0.47316347 |
| 95 | MP0003943_abnormal_hepatobiliary_system | 0.46600665 |
| 96 | MP0005334_abnormal_fat_pad | 0.45543943 |
| 97 | MP0004185_abnormal_adipocyte_glucose | 0.44262195 |
| 98 | MP0003959_abnormal_lean_body | 0.44148745 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.43591145 |
| 100 | MP0001765_abnormal_ion_homeostasis | 0.43137068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.56891962 |
| 2 | T lymphocytopenia (HP:0005403) | 6.31999566 |
| 3 | Abnormality of T cell number (HP:0011839) | 5.76003368 |
| 4 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.59111482 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.23572544 |
| 6 | Recurrent cutaneous fungal infections (HP:0011370) | 5.18267105 |
| 7 | Chronic mucocutaneous candidiasis (HP:0002728) | 5.18267105 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.89084795 |
| 9 | Myositis (HP:0100614) | 4.69218910 |
| 10 | Encephalitis (HP:0002383) | 4.68026799 |
| 11 | Abnormality of T cells (HP:0002843) | 4.66839713 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 4.64157462 |
| 13 | Stomatitis (HP:0010280) | 4.55473372 |
| 14 | Recurrent abscess formation (HP:0002722) | 4.47668268 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 4.40547031 |
| 16 | Abnormality of macrophages (HP:0004311) | 4.36861343 |
| 17 | Orchitis (HP:0100796) | 4.35716577 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 4.35396819 |
| 19 | Optic neuritis (HP:0100653) | 4.35396819 |
| 20 | Meningitis (HP:0001287) | 4.14154134 |
| 21 | Recurrent skin infections (HP:0001581) | 4.05277890 |
| 22 | Recurrent bronchitis (HP:0002837) | 4.01828249 |
| 23 | Increased IgE level (HP:0003212) | 3.83577323 |
| 24 | Agammaglobulinemia (HP:0004432) | 3.81613478 |
| 25 | Recurrent viral infections (HP:0004429) | 3.53971157 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 3.52156738 |
| 27 | Severe combined immunodeficiency (HP:0004430) | 3.47445447 |
| 28 | Leukocytosis (HP:0001974) | 3.44291524 |
| 29 | Spontaneous hematomas (HP:0007420) | 3.42349579 |
| 30 | Vasculitis (HP:0002633) | 3.41066977 |
| 31 | Pustule (HP:0200039) | 3.30775052 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 3.29447677 |
| 33 | Obstructive lung disease (HP:0006536) | 3.29447677 |
| 34 | Keratoconjunctivitis sicca (HP:0001097) | 3.21187863 |
| 35 | Abnormality of T cell physiology (HP:0011840) | 3.19482246 |
| 36 | Mediastinal lymphadenopathy (HP:0100721) | 3.18226710 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.16073603 |
| 38 | Abnormality of eosinophils (HP:0001879) | 3.15950779 |
| 39 | Inflammation of the large intestine (HP:0002037) | 3.15268211 |
| 40 | IgG deficiency (HP:0004315) | 3.11774861 |
| 41 | Gastrointestinal inflammation (HP:0004386) | 3.11289775 |
| 42 | Chronic diarrhea (HP:0002028) | 3.08231092 |
| 43 | Gingivitis (HP:0000230) | 3.07628724 |
| 44 | Granulocytopenia (HP:0001913) | 3.03959532 |
| 45 | Pulmonary infiltrates (HP:0002113) | 2.97909589 |
| 46 | Eosinophilia (HP:0001880) | 2.97528885 |
| 47 | Colitis (HP:0002583) | 2.95309063 |
| 48 | Keratoconjunctivitis (HP:0001096) | 2.94669648 |
| 49 | Increased IgM level (HP:0003496) | 2.83491045 |
| 50 | Chest pain (HP:0100749) | 2.80303711 |
| 51 | Viral hepatitis (HP:0006562) | 2.78497587 |
| 52 | Hypoplasia of the thymus (HP:0000778) | 2.73661211 |
| 53 | Joint swelling (HP:0001386) | 2.73387654 |
| 54 | Combined immunodeficiency (HP:0005387) | 2.64798333 |
| 55 | Lymphopenia (HP:0001888) | 2.62809934 |
| 56 | Hemiplegia (HP:0002301) | 2.60820780 |
| 57 | Petechiae (HP:0000967) | 2.55174071 |
| 58 | Autoimmune hemolytic anemia (HP:0001890) | 2.52826450 |
| 59 | Hypoproteinemia (HP:0003075) | 2.50650208 |
| 60 | Hypochromic microcytic anemia (HP:0004840) | 2.45553634 |
| 61 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.44487185 |
| 62 | Hypochromic anemia (HP:0001931) | 2.42591438 |
| 63 | Nasal polyposis (HP:0100582) | 2.41308964 |
| 64 | Hemoptysis (HP:0002105) | 2.41203031 |
| 65 | Chronic otitis media (HP:0000389) | 2.40956509 |
| 66 | Pulmonary embolism (HP:0002204) | 2.38154309 |
| 67 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.38130957 |
| 68 | Urticaria (HP:0001025) | 2.35828524 |
| 69 | Anorexia (HP:0002039) | 2.32076963 |
| 70 | Abnormality of the pleura (HP:0002103) | 2.31059391 |
| 71 | Prolonged bleeding time (HP:0003010) | 2.29860565 |
| 72 | Hypergammaglobulinemia (HP:0010702) | 2.26319406 |
| 73 | Arterial thrombosis (HP:0004420) | 2.25402593 |
| 74 | Gingival bleeding (HP:0000225) | 2.23957258 |
| 75 | Bronchitis (HP:0012387) | 2.21208226 |
| 76 | Slow saccadic eye movements (HP:0000514) | 2.19761631 |
| 77 | Cellulitis (HP:0100658) | 2.16537330 |
| 78 | Abnormality of the fingertips (HP:0001211) | 2.14818502 |
| 79 | Microcytic anemia (HP:0001935) | 2.14596573 |
| 80 | Glomerulopathy (HP:0100820) | 2.13691969 |
| 81 | Epistaxis (HP:0000421) | 2.13615648 |
| 82 | Pigmentary retinal degeneration (HP:0001146) | 2.12065681 |
| 83 | Sepsis (HP:0100806) | 2.08823907 |
| 84 | Osteomyelitis (HP:0002754) | 2.08185312 |
| 85 | Lymphoma (HP:0002665) | 2.04541361 |
| 86 | Episodic fever (HP:0001954) | 2.03579170 |
| 87 | Purpura (HP:0000979) | 2.03207541 |
| 88 | Acne (HP:0001061) | 2.02442962 |
| 89 | Papilledema (HP:0001085) | 2.01791535 |
| 90 | Gangrene (HP:0100758) | 2.00222111 |
| 91 | Abnormality of the pericardium (HP:0001697) | 2.00071319 |
| 92 | Micronodular cirrhosis (HP:0001413) | 1.99923331 |
| 93 | Abnormality of binocular vision (HP:0011514) | 1.99732541 |
| 94 | Diplopia (HP:0000651) | 1.99732541 |
| 95 | Basal ganglia calcification (HP:0002135) | 1.97923809 |
| 96 | Stomach cancer (HP:0012126) | 1.97264301 |
| 97 | Thyroiditis (HP:0100646) | 1.92055216 |
| 98 | Abnormality of the nasal mucosa (HP:0000433) | 1.91635031 |
| 99 | Subacute progressive viral hepatitis (HP:0006572) | 1.88763097 |
| 100 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.88047819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.04336506 |
| 2 | MAP4K1 | 4.73904874 |
| 3 | EPHB1 | 3.71014471 |
| 4 | RIPK4 | 3.00165963 |
| 5 | EPHA3 | 2.95927266 |
| 6 | CDK3 | 2.92164585 |
| 7 | IRAK4 | 2.66805112 |
| 8 | MAP2K3 | 2.60202816 |
| 9 | FES | 2.35610041 |
| 10 | CSK | 2.32766875 |
| 11 | JAK1 | 2.16856618 |
| 12 | STK10 | 2.16069284 |
| 13 | MAP3K3 | 2.10456597 |
| 14 | FGFR4 | 1.94417823 |
| 15 | TGFBR2 | 1.92175391 |
| 16 | BLK | 1.90951450 |
| 17 | ZAP70 | 1.88060420 |
| 18 | FRK | 1.85271883 |
| 19 | TNK2 | 1.83463602 |
| 20 | TYK2 | 1.82625995 |
| 21 | GRK7 | 1.68197402 |
| 22 | BTK | 1.67441569 |
| 23 | GRK6 | 1.58291260 |
| 24 | JAK3 | 1.56964694 |
| 25 | ITK | 1.42374627 |
| 26 | PRPF4B | 1.40422251 |
| 27 | TAOK1 | 1.38661144 |
| 28 | HCK | 1.38048805 |
| 29 | TAOK3 | 1.36220492 |
| 30 | SYK | 1.34657429 |
| 31 | FGFR3 | 1.33352420 |
| 32 | MOS | 1.30037602 |
| 33 | LCK | 1.26484244 |
| 34 | ERN1 | 1.25078382 |
| 35 | SIK3 | 1.24354170 |
| 36 | SGK3 | 1.21916914 |
| 37 | HIPK2 | 1.20149244 |
| 38 | IRAK1 | 1.17289067 |
| 39 | SGK2 | 1.12070102 |
| 40 | NLK | 1.11455083 |
| 41 | MARK3 | 1.11450003 |
| 42 | TRIB3 | 1.05008058 |
| 43 | TEC | 1.03381572 |
| 44 | PDK1 | 0.99142736 |
| 45 | MAP3K1 | 0.96366150 |
| 46 | LYN | 0.93519729 |
| 47 | IKBKE | 0.93481125 |
| 48 | JAK2 | 0.93172321 |
| 49 | STK38 | 0.89088807 |
| 50 | MAPK12 | 0.88505983 |
| 51 | MARK2 | 0.83199852 |
| 52 | PRKCQ | 0.79820174 |
| 53 | MAP3K13 | 0.77742702 |
| 54 | PRKCH | 0.75506039 |
| 55 | GRK5 | 0.71867573 |
| 56 | IKBKB | 0.71190713 |
| 57 | MAP2K6 | 0.70030493 |
| 58 | FGR | 0.69859448 |
| 59 | KIT | 0.67919687 |
| 60 | MAP3K14 | 0.67141637 |
| 61 | PTK2B | 0.66285911 |
| 62 | SGK223 | 0.64016523 |
| 63 | SGK494 | 0.64016523 |
| 64 | SIK2 | 0.63423244 |
| 65 | CDK4 | 0.63190361 |
| 66 | PIK3CG | 0.61514579 |
| 67 | MAP3K11 | 0.58580936 |
| 68 | PIM1 | 0.56994463 |
| 69 | YES1 | 0.56480619 |
| 70 | PRKD2 | 0.55409830 |
| 71 | TBK1 | 0.51128849 |
| 72 | PRKCE | 0.50815269 |
| 73 | CSF1R | 0.49798130 |
| 74 | PRKCG | 0.48609564 |
| 75 | FYN | 0.48586565 |
| 76 | RET | 0.46158473 |
| 77 | MAPKAPK2 | 0.45829370 |
| 78 | SMG1 | 0.44358247 |
| 79 | LRRK2 | 0.38702563 |
| 80 | KSR2 | 0.38552275 |
| 81 | DAPK2 | 0.38272447 |
| 82 | CSNK1D | 0.38052635 |
| 83 | MAPK7 | 0.37175047 |
| 84 | BMPR2 | 0.35735622 |
| 85 | RPS6KA4 | 0.35515253 |
| 86 | ADRBK1 | 0.33469435 |
| 87 | RPS6KL1 | 0.32072329 |
| 88 | RPS6KC1 | 0.32072329 |
| 89 | STK11 | 0.31704180 |
| 90 | CAMK4 | 0.31295869 |
| 91 | CAMKK2 | 0.31223641 |
| 92 | PTK6 | 0.30341182 |
| 93 | RPS6KA6 | 0.30303199 |
| 94 | PDPK1 | 0.29436017 |
| 95 | CHUK | 0.28637318 |
| 96 | MAP3K8 | 0.28514513 |
| 97 | DYRK1B | 0.28371764 |
| 98 | CDK12 | 0.27756687 |
| 99 | TESK2 | 0.22173471 |
| 100 | MAP3K7 | 0.22051330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 5.54043618 |
| 2 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 4.35025123 |
| 3 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.29066855 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.61418221 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.56705152 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.46418664 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.45701094 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.27361714 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.06660032 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.02282247 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.01447134 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.00237989 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.98223305 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96005617 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.93051931 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.59408775 |
| 17 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.54018587 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.53668543 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.50563914 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.50529212 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.50331194 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48431609 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.41374673 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.39983137 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39197114 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.29913897 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21812239 |
| 28 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.18062935 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17860903 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.17171807 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.16476669 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16440082 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.15412643 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13581998 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.09674879 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08146545 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.06825638 |
| 38 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.02840578 |
| 39 | Platelet activation_Homo sapiens_hsa04611 | 0.99551028 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 0.96078310 |
| 41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.95577043 |
| 42 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.92096567 |
| 43 | Asthma_Homo sapiens_hsa05310 | 0.91204994 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86571970 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 0.84793557 |
| 46 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81695740 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 0.79484872 |
| 48 | Endocytosis_Homo sapiens_hsa04144 | 0.77838436 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76851495 |
| 50 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76354889 |
| 51 | Phagosome_Homo sapiens_hsa04145 | 0.75623980 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73625891 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 0.70072213 |
| 54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68030252 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65959303 |
| 56 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65554587 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64182849 |
| 58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63447044 |
| 59 | Legionellosis_Homo sapiens_hsa05134 | 0.61802734 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61238354 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60641027 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.60394439 |
| 63 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60096971 |
| 64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59637907 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58282110 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57747697 |
| 67 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56263483 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56196975 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54318998 |
| 70 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51903064 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51086552 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50070785 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.44975621 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44520288 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43680761 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42099521 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.41769507 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40239687 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39944027 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39797700 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39758297 |
| 82 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39569658 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37364519 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35968852 |
| 85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35221952 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34602556 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34192112 |
| 88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33062396 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33002509 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32641719 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32021104 |
| 92 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.29538365 |
| 93 | Prostate cancer_Homo sapiens_hsa05215 | 0.29205852 |
| 94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28874018 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27006109 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.25867458 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.25176880 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.24152054 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.24092458 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.23974077 |

